SAMLYN CAPITAL, LLC Q4 2016 Filing
Filed February 14, 2017
Portfolio Value
$4.4T
Holdings
114
Report Date
Q4 2016
Filing Type
13F-HR
All Holdings (114 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | KEXKIRBY CORP | 63,971 | $4.3B | 0.10% | |
| 102 | SG7SAGE THERAPEUTICS INC | 82,000 | $4.2B | 0.09% | |
| 103 | ALXNALEXION PHARMACEUTICALS INC | 34,000 | $4.2B | 0.09% | |
| 104 | PCRXPACIRA PHARMACEUTICALS INC | 127,000 | $4.1B | 0.09% | |
| 105 | —MOMENTA PHARMACEUTICALS INC | 264,000 | $4.0B | 0.09% | |
| 106 | NVROEURNEVRO CORP | 54,000 | $3.9B | 0.09% | |
| 107 | ISIIONIS PHARMACEUTICALS INC | 81,000 | $3.9B | 0.09% | |
| 108 | RAREULTRAGENYX PHARMACEUTICAL IN | 55,000 | $3.9B | 0.09% | |
| 109 | —DERMIRA INC | 127,000 | $3.9B | 0.09% | |
| 110 | VRTXVERTEX PHARMACEUTICALS INC | 52,000 | $3.8B | 0.09% | |
| 111 | INCYINCYTE CORP | 38,000 | $3.8B | 0.09% | |
| 112 | —ALDER BIOPHARMACEUTICALS INC | 180,000 | $3.7B | 0.08% | |
| 113 | ACRSACLARIS THERAPEUTICS INC | 136,000 | $3.7B | 0.08% | |
| 114 | —WMIH CORP | 53,420 | $83.0M | 0.00% |
PreviousPage 2 of 2